• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a pr

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Apr 30;14(1):9957.
doi: 10.1038/s41598-024-60372-4. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study

Snehal M Pinto Pereira[SUP] 1 [/SUP], Manjula D Nugawela[SUP] 2 [/SUP], Terence Stephenson[SUP] 2 [/SUP], Paul Foret-Bruno[SUP] 2 3 [/SUP], Emma Dalrymple[SUP] 2 [/SUP], Laila Xu[SUP] 2 [/SUP], Elizabeth Whittaker[SUP] 4 5 [/SUP], Isobel Heyman[SUP] 2 [/SUP], Tamsin Ford[SUP] 6 [/SUP], Terry Segal[SUP] 7 [/SUP], Trudie Chalder[SUP] 8 [/SUP], Shamez N Ladhani[SUP] 9 [/SUP], Anna A Mensah[SUP] 9 [/SUP], Kelsey McOwat[SUP] 9 [/SUP], Ruth Simmons[SUP] 9 [/SUP]; CLoCk Consortium; Roz Shafran[SUP] 10 [/SUP]



Collaborators, Affiliations
Abstract

Our previous study in children and young people (CYP) at 3- and 6-months post-infection showed that 12-16% of those infected with the Omicron (B.1.1.529) variant of SARS-CoV-2 met the research definition of Long Covid, with no differences between first-positive and reinfected CYP. The primary objective of the current study is to explore the impact of the Omicron variant of SARS-CoV-2 infection on young people 12 months post infection. 345 CYP aged 11-17 years with a first laboratory-confirmed infection with the Omicron variant and 360 CYP reinfected with the Omicron variant completed an online questionnaire assessing demographics, symptoms, and their impact shortly after testing and again at 3-, 6-and 12-months post-testing. Vaccination status was determined from information held at UKHSA. Comparisons between groups were made using chi-squared, Mann-Whitney U, and Kruskal-Wallis tests. The most common symptoms in first-positive and reinfected CYP 12-months post-testing were tiredness (35.7 and 33.6% respectively) and sleeping difficulties (27.5 and 28.3% respectively). Symptom profiles, severity and impact were similar in the two infection status groups. Overall, by 12-months, 17.4% of first-positives and 21.9% of reinfected CYP fulfilled the research consensus Long Covid definition (p = 0.13). 12-months post Omicron infection, there is little difference between first-positive and reinfected CYP with respect to symptom profiles and impact. Clinicians may not therefore need to consider number of infections and type of variant when developing treatment plans. Further studies are needed to assess causality of reported symptoms up to 12-months after SARS-CoV-2 infection.

Keywords: Long Covid; Omicron; Post Covid-19 condition; Prospective; Young people.

 
Back
Top Bottom